* OrthoPediatrics Corp KIDS.OQ KIDS.O is expected
to show a
rise in quarterly revenue when it reports results on February
28.
* The Warsaw Indiana Indiana-based company is expected to
report
a 31.5% increase in revenue to $32.622 million from $24.81
million a year ago, according to the mean estimate from 7
analysts, based on Refinitiv data. The company's guidance on
January 9 2023, for the period ended December 31, was for
revenue of $31.000 million.
* Refinitiv's mean analyst estimate for OrthoPediatrics
Corp is
for a loss of 25 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for
OrthoPediatrics
Corp is $54, above its last closing price of $43.79.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Sep. 30 2022 -0.20 -0.20 -0.07 Beat 65.7
Jun. 30 2022 -0.22 -0.21 -0.02 Beat 90.7
Mar. 31 2022 -0.38 -0.37 -0.47 Missed -26.7
Dec. 31 2021 -0.31 -0.30 0.00 Beat 100
Sep. -0.28 -0.28 -0.11 Beat 60.5
30 2021
Jun. 30 2021 -0.35 -0.34 -0.19 Beat 44.8
Mar. 31 2021 -0.27 -0.27 -0.47 Missed -76.5
Dec. 31 2020 -0.36 -0.27 -0.73 Missed -168.4
This summary was machine generated February 25 at 01:17 GMT.
All figures in US dollars unless otherwise stated